BridgeBio Pharma, Inc. (BBIO)
76.04
-2.14
(-2.74%)
USD |
NASDAQ |
Nov 20, 16:00
78.68
+2.64
(+3.47%)
After-Hours: 19:22
BridgeBio Pharma Gross Profit (TTM) : 890.06M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 890.06M |
| June 30, 2026 | 671.14M |
| March 31, 2026 | 549.16M |
| December 31, 2025 | 478.38M |
| September 30, 2025 | 336.08M |
| June 30, 2025 | 223.53M |
| March 31, 2025 | 117.53M |
| December 31, 2024 | 213.45M |
| September 30, 2024 | 210.28M |
| June 30, 2024 | 211.54M |
| March 31, 2024 | 210.95M |
| December 31, 2023 | 1.863M |
| September 30, 2023 | 2.164M |
| June 30, 2023 | -1.436M |
| March 31, 2023 | 70.92M |
| December 31, 2022 | 70.14M |
| September 30, 2022 | 81.09M |
| June 30, 2022 | 83.42M |
| Date | Value |
|---|---|
| March 31, 2022 | 62.59M |
| December 31, 2021 | 63.23M |
| September 30, 2021 | 52.12M |
| June 30, 2021 | 59.36M |
| March 31, 2021 | 8.127M |
| December 31, 2020 | 8.127M |
| September 30, 2020 | 8.127M |
| June 30, 2020 | 24.24M |
| March 31, 2020 | 24.24M |
| December 31, 2019 | 24.13M |
| September 30, 2019 | 24.03M |
| June 30, 2019 | -0.289M |
| March 31, 2019 | -0.331M |
| December 31, 2018 | -0.245M |
| September 30, 2018 | -0.145M |
| June 30, 2018 | -0.068M |
| March 31, 2018 | -0.026M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.874B |
| Ionis Pharmaceuticals, Inc. | 915.88M |
| Cytokinetics, Inc. | 89.41M |
| Pfizer Inc. | 41.42B |
| Ultragenyx Pharmaceutical, Inc. | 571.22M |